Skip to main content
Back
Watch Compare

Incannex Healthcare Inc.

Data quality: 100%
IXHL
Nasdaq Manufacturing Chemicals
$3.12
▲ $0.24 (8.33%)
Mkt Cap: 39.82 M
Price
$2.85
Mkt Cap
39.82 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -20.34 M
Capital intensive — 268.37% of revenue goes to capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-38.17%
Above sector avg (-53.41%)
ROIC-28.25%
Net Margin-29288.78%
Op. Margin-27467.35%

Safety

Debt / Equity
N/A
Current Ratio48.27
Interest CoverageN/A

Valuation

PE (TTM)
-1.39
Above sector avg (-1.48)
P/B Ratio0.54
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.4 -1.5
P/B 0.5 1.6
ROE % -38.2 -53.4
Net Margin % -29288.8 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
1.28% weight
BRSIX BRSIX
0.02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 98,000.0 Net Income (TTM) -28.70 M
ROE -38.17% ROA -37.34%
Gross Margin N/A Operating Margin -27467.35%
Net Margin -29288.78% Free Cash Flow (TTM) -20.34 M
ROIC -28.25% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 48.27
Interest Coverage N/A Asset Turnover 0.00
Working Capital 73.13 M Tangible Book Value 73.41 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.39 Forward P/E N/A
P/B Ratio 0.54 P/S Ratio 406.38
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -51.08%
Market Cap 39.82 M Enterprise Value -29.08 M
Per Share
EPS (Diluted TTM) -0.89 Revenue / Share 0.01
FCF / Share -1.46 OCF / Share -1.47
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 268.37% FCF Conversion 70.87%
SBC-Adj. FCF -27.78 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2025 FY2022
Revenue 12,000.0 — —
Net Income -18.46 M -46.89 M —
EPS (Diluted) -1.15 -1.35 —
Gross Profit — — —
Operating Income -30.04 M -23.79 M —
EBITDA — — —
R&D Expenses 12.88 M 10.75 M —
SG&A Expenses — — —
D&A 103,000.0 246,000.0 —
Interest Expense — 303,000.0 —
Income Tax 30,000.0 30,000.0 —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2025
Total Assets 17.05 M 20.45 M
Total Liabilities 5.83 M 7.06 M
Shareholders' Equity 11.22 M 13.39 M
Total Debt — —
Cash & Equivalents 5.86 M 15.04 M
Current Assets 16.20 M 19.96 M
Current Liabilities 5.62 M 6.98 M